Cabaletta Bio, Inc. ( CABA) - Key Metrics
CABA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.34 | -$0.27 | -$0.27 |
| 2026Q1 | $0 | -$0.39 | -$0.38 | -$0.38 |
| 2025Q4 | $0 | -$0.41 | -$0.35 | -$0.35 |
| 2025Q3 | $0 | -$0.44 | -$0.34 | -$0.34 |
| 2025Q2 | $0 | -$0.73 | -$0.49 | -$0.49 |
CABA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.29 |
| 2026Q1 | 0% | -1.72 |
| 2025Q4 | 0% | -1.34 |
| 2025Q3 | 0% | -1.33 |
| 2025Q2 | 0% | -0.52 |
CABA
Price: $1.41
52 week price:
Earnings Per Share: -1.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 489500
Market Capitalization: 326.1 million